Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Jaguar Health (JAGX) Asset Writedowns and Impairment (2019)

Jaguar Health (JAGX) has disclosed Asset Writedowns and Impairment for 1 consecutive years, with $4.0 million as the latest value for Q2 2019.

Quarterly Asset Writedowns and Impairment changed N/A to $4.0 million in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Jun 2020, changed 0.0% year-over-year, with the annual reading at $800000.0 for FY2025, N/A changed from the prior year.
Asset Writedowns and Impairment for Q2 2019 was $4.0 million at Jaguar Health.
The five-year high for Asset Writedowns and Impairment was $4.0 million in Q2 2019, with the low at $4.0 million in Q2 2019.